To compare the effectiveness of two different types of tubes

Not yet recruiting

• Conditions: Medical and Surgical,

• Registration Number: CTRI/2023/01/048788
• Lead Sponsor: S M Kushal

Brief Summary

Supraglottic airway devices (SADs) play a criticalrole in the airway management.

In any situation where intubation cant be done, theAmerican Society of Anesthesiologists (ASA), Difficult Airway Society (DAS),and Obstetric Anaesthetists’ Association and DAS guidelines recommends the useof SADs as conduit for tracheal intubation.

The FastrachTM-laryngeal mask airway was designed to provide bothventilation and ability to pass a tracheal tube blindly into the trachea.

TheAmbu Auraâ€i is singleâ€use intubating SAD, also designed forboth ventilation and as a conduit for tracheal intubation.

| |

| --- |

|After extensive research on the literature, it is found that there is not enough data available on the tracheal intubation assessment with Ambu Aura-i. Hence, the present study will be done to compare the tracheal intubation using FTâ€LMA and Auraâ€i in adults.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-05-01
• Study Start: 2023-09-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

·Age 18 to 60 years ·ASA 1 and 2.

Exclusion Criteria

·Younger than 18 years old ·American Society of Anaesthesiologists physical status IV or V · Diagnosed with respiratory tract pathology or coagulation disorders requiring a nasal route for tracheal intubation ·Those at risk of regurgitation–aspiration (previous upper gastrointestinal tract surgery, known hiatus hernia, esophageal reflux, peptic ulceration, or not fasted).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) To evaluate the effectiveness of intubation with Fastrach TM LMA and Ambu aura-i in Anticipated Difficult Airway Management	18 months
2) To evaluate the time taken and number of attempts for intubation with FastrachTM and Ambu Aura-i in Anticipated Difficult Airway Management.	18 months

Secondary Outcome Measures

Name	Time	Method
FastrachTM intubating LMA is better than Ambu aura-i LMA	18 months

Trial Locations

Locations (1)

RL Jalappa Hospital; 🇮🇳 Kolar, KARNATAKA, India

RL Jalappa Hospital

🇮🇳Kolar, KARNATAKA, India

Dr Ravi Madhusudhana

Principal investigator

9845287591

ravijaggu@gmail.com